Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This first-in-man trial forms the basis for potential clinical development of BI 144807 in the indications of asthma and allergic rhinitis. The safety, tolerability, pharmacokinetics, and pharmacodynamics of single rising doses of BI 144807 will be assessed in healthy male volunteers.
Epistemonikos ID: f797e7b522eef8274bf26a7d1a5b3c3f81d02e8a
First added on: May 10, 2024